Advances in Alzheimer's imaging are changing the experience of Alzheimer's disease

Abstract Neuroimaging is advancing a new definition of Alzheimer's disease (AD). Using imaging biomarkers, clinicians may begin to diagnose the disease by identifying pathology and neurodegeneration in either cognitively impaired or unimpaired adults. This “biomarker‐based” diagnosis may allow...

Full description

Bibliographic Details
Main Authors: Shana D. Stites, Richard Milne, Jason Karlawish
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring
Subjects:
Online Access:https://doi.org/10.1016/j.dadm.2018.02.006